FDA.reportPublic FDA data

Myhibbin 200 MG in 1 mL Oral Suspension

RxCUI
2684851
RxNorm name
Myhibbin 200 MG in 1 mL Oral Suspension
Display name
Myhibbin 200 MG in 1 mL Oral Suspension
Full name
Myhibbin 200 MG in 1 mL Oral Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
d9af72d6-7b3e-4c08-94b9-1d8b499cb7f9Myhibbin 200 MG in 1 mL Oral Suspension [PSN] · mycophenolate mofetil 200 MG/ML Oral Suspension [Myhibbin] [SBD] · Myhibbin 200 MG per 1 ML Oral Suspension [SY] · Myhibbin 200 MG/ML Oral Suspension [SY]45These highlights do not include all the information needed to use MYHIBBIN safely and effectively. See full prescribing information for MYHIBBIN. MYHIBBIN ® (mycophenolate mofetil oral suspension) Initial U.S. Approval: 199520260401